Related Experiment Video
Updated: Mar 26, 2026

Unraveling Entropic Rate Acceleration Induced by Solvent Dynamics in Membrane Enzymes
Published on: January 16, 2016
Intrinsic thermodynamics of inhibitor binding to human carbonic anhydrase IX
Vaida Linkuvienė1, Jurgita Matulienė1, Vaida Juozapaitienė1
1Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Vilnius University, Graičiūno 8, Vilnius LT-02241, Lithuania.
Background:
Human carbonic anhydrase 9th isoform (CA IX) is an important marker of numerous cancers and is increasingly interesting as a potential anticancer drug target. Various synthetic aromatic sulfonamide-bearing compounds are being designed as potent inhibitors of CA IX. However, sulfonamide compound binding to CA IX is linked to several reactions, the deprotonation of the sulfonamide amino group and the protonation of the CA active site Zn(II)-bound hydroxide. These linked reactions significantly affect the affinities and other thermodynamic parameters such as enthalpies and entropies of binding.
Methods:
The observed and intrinsic affinities of compound binding to CA IX were determined by the fluorescent thermal shift assay. The enthalpies and entropies of binding were determined by the isothermal titration calorimetry.
Results:
The pKa of CA IX was determined to be 6.8 and the enthalpy of CA IX-Zn(II)-bound hydroxide protonation was -24 kJ/mol. These values enabled the analysis of intrinsic thermodynamics of a library of compounds binding to CA IX. The most strongly binding compounds exhibited the intrinsic affinity of 0.01 nM and the observed affinity of 2 nM.
Conclusions:
The intrinsic thermodynamic parameters of compound binding to CA IX helped to draw the compound structure to thermodynamics relationship.
General Significance:
It is important to distinguish the intrinsic from observed parameters of any disease target protein interaction with its inhibitors as drug candidates when drawing detailed compound structure to thermodynamics correlations.
Insights
This study quantifies the binding thermodynamics of carbonic anhydrase 9th isoform (CA IX) inhibitors. Differentiating intrinsic from observed binding parameters is crucial for developing effective anticancer drugs targeting CA IX.
Area of Science:
- Biochemistry
- Chemical Biology
- Pharmacology
Background:
- Human carbonic anhydrase 9th isoform (CA IX) is a key cancer marker and therapeutic target.
- Aromatic sulfonamide compounds are investigated as CA IX inhibitors.
- Sulfonamide binding involves linked reactions affecting thermodynamic parameters.
Purpose of the Study:
- To determine the intrinsic thermodynamic parameters of CA IX inhibitor binding.
- To establish structure-thermodynamics relationships for CA IX inhibitors.
- To differentiate observed from intrinsic binding parameters for drug development.
Main Methods:
- Fluorescent thermal shift assay to measure binding affinities (observed and intrinsic).
- Isothermal titration calorimetry to determine binding enthalpies and entropies.
- Determination of CA IX pKa and hydroxide protonation enthalpy.
Main Results:
- CA IX pKa determined as 6.8; hydroxide protonation enthalpy as -24 kJ/mol.
- Intrinsic affinities down to 0.01 nM and observed affinities of 2 nM were measured.
- Analysis enabled the correlation of compound structure with binding thermodynamics.
Conclusions:
- Intrinsic thermodynamic parameters are key for understanding CA IX inhibitor interactions.
- Distinguishing intrinsic from observed parameters is vital for drug candidate development.
- This work facilitates the design of novel CA IX-targeting anticancer agents.
Related Concept Videos
Introduction to Mechanisms of Enzyme Catalysis
Enzyme Inhibition
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
ATP Synthase: Mechanism
Feedback Inhibition

